Product Catalog

SemaglutideSpecifications & Batch COA

GLP-1 receptor agonist for type 2 diabetes and chronic weight management. Widely used in clinical and wellness protocols.

KERUIHK-0101Semaglutide product vial
Lyophilized PowderProduct image
Weight Loss & Metabolic

Semaglutide

GMPKERUIHK-0101

GLP-1 receptor agonist for type 2 diabetes and chronic weight management. Widely used in clinical and wellness protocols.

Product Specifications

CAS Number
910463-68-2
Catalog Purity
≥99.32%
Form
Lyophilized Powder
Catalog Grade
GMP
View batch documentation

Product Details

Semaglutide specifications

Use the product name, catalog reference and available specifications below when discussing your requirements with our team.

Product
Semaglutide
Catalog reference
KERUIHK-0101
CAS number
910463-68-2
Category
Weight Loss & Metabolic
Physical form
Lyophilized Powder

Latest reported batch: Semaglutide

Batch PB-2026-SEM-8216 · Oct 14, 2026

Reported appearance
White lyophilized powder
Reported molecular weight / identity
4113.81 Da
Analytical method
RP-HPLC / ESI-MS

Reported analytical results

HPLC Purity
99.47%Report specification: ≥99.0%
Molecular Weight (MS)
4113.81 DaReport specification: 4113.58 ± 0.5 Da
Amino Acid Analysis
ConformsReport specification: Conforms to sequence
Endotoxin (LAL)
0.43 EU/mgReport specification: < 1.0 EU/mg
Show 5 more test results
Sterility (USP <71>)
No growth observedReport specification: No evidence of microbial growth
Residual Solvents
< ICH Q3C limitsReport specification: ICH Q3C Class 2
Water Content (KF)
4.98%Report specification: ≤ 8.0%
Optical Rotation
-29.4 °Report specification: -25° to -32°
Peptide Content (AAA)
95.90%Report specification: ≥95.0%
Source COA: PB-2026-SEM-8216-R20261014
Explore this category

Batch Documentation

Certificates of Analysis

Open a batch below to view its full report in our COA library, including available analytical attachments and PDF download.

PB-2026-SEM-8216Report product: SemaglutideOct 14, 2026 · Reported purity: 99.47%View this batch COA
PB-2026-SEM-8216Report product: SemaglutideSep 04, 2026 · Reported purity: 99.4%View this batch COA
PB-2026-SEM-0163Report product: SemaglutideJun 23, 2026 · Reported purity: 99.3%View this batch COA
Show 4 earlier reports
PB-2026-SEM-0312Report product: SemaglutideMar 28, 2026 · Reported purity: 99.4%View this batch COA
PB-2025-SEM-0278Report product: SemaglutideDec 14, 2025 · Reported purity: 99.2%View this batch COA
PB-2025-SEM-0201Report product: SemaglutideSep 03, 2025 · Reported purity: 99.1%View this batch COA
PB-2025-SEM-0144Report product: SemaglutideJun 10, 2025 · Reported purity: 99.3%View this batch COA

Product Inquiry

Request a Semaglutide quotation

We synthesize any sequence at any scale — from milligram research quantities to multi-kilogram commercial batches. OEM, private label, and GMP manufacturing available. Response within 24 hours.

Discuss your requirements
Back to all products